Unlocking KOL & DOL Insights at a Premier Oncology Congress
RILA Global Consulting partnered with a leading global biopharmaceutical company to deliver real-time digital opinion leader (DOL) and key opinion leader (KOL) insights during a major U.S. lung cancer congress. Using social listening across platforms like X (Twitter), LinkedIn, Facebook, and Instagram, RILA monitored over 100 healthcare professionals and stakeholders to analyze perceptions around therapies, unmet needs, and clinical innovations in areas like small cell lung cancer and immunotherapy. Their strategy involved live monitoring, sentiment analysis, influencer profiling, and competitive benchmarking to identify top oncology voices and inform both local and global strategies. The results provided actionable intelligence for medical affairs and commercial teams, helping refine future engagement plans and optimize field activities. RILA, a leader in pharma-focused digital analytics, emphasized secure, ethical data practices and high-impact insights across the product lifecycle.